Results 351 to 360 of about 536,830 (388)

Comparative efficacy of glioma treatment strategies: an umbrella review of meta-analyses. [PDF]

Ann Med
Yang E, Yang Y, Gao Y, Liu X, Liu X, Zong X, Li J.   +6 more
europepmc   +1 more source

[Corrigendum] lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling. [PDF]

Mol Med Rep
Tang T, Wang LX, Yang ML, Zhang RM.
europepmc   +1 more source

Performance Evaluation of Artificial Intelligence Techniques in the Diagnosis of Brain Tumors: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Al-Rumaihi G, Khan MM, Saleh A, Ali A, Al-Romaihi L, Al-Jaber N, Al-Suliaiti G, Chowdhury ME, Rathnaiah Babu G, Pedersen S.   +9 more
europepmc   +1 more source

Hsa_circ_0059511 promote glioma cell proliferation and migration through hsa-miR-194-5p/HBEGF axis. [PDF]

Cancer Cell Int
Jing Y, Shang-Guan HC, Cai J, Su J, Huang W, He Q, Chen X, Kang D, Wu Z.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Glioma

Nature Reviews Disease Primers
Gliomas are primary brain tumours that are thought to develop from neural stem or progenitor cells that carry tumour-initiating genetic alterations. Based on microscopic appearance and molecular characteristics, they are classified according to the WHO classification of central nervous system (CNS) tumours and graded into CNS WHO grades 1-4 from a low ...
Michael Weller, P. Y. Wen, Susan M. Chang, L. Dirven, Michael Lim, Michelle Monje, G. Reifenberger   +6 more
semanticscholar   +4 more sources

Gliomas in Children [PDF]

Current Treatment Options in Neurology, 2013
Gliomas are the most common brain tumor in children and represent nearly 50 % of all pediatric central nervous system (CNS) tumors. They are a heterogeneous group of diseases, ranging from highly malignant and frequently fatal to histologically benign and curable by surgery alone.
Michael Fisher, Michael Fisher, Jane E. Minturn   +2 more
openaire   +2 more sources

Radiogenomics of Gliomas

Radiologic Clinics of North America, 2021
The 2016 World Health Organization brain tumor classification is based on genomic and molecular profile of tumor tissue. These characteristics have improved understanding of the brain tumor and played an important role in treatment planning and prognostication.
Sangam Kanekar, Chaitra Badve
openaire   +3 more sources

Gliomas

2013
Gliomas are thought to arise from the glial cells of brain tissue. The spectrum of tumours varies with age, implying that cells in a particular state of development are a prerequisite for the occurrence of some tumour types. Premalignant states are not recognized, so we know little about the earliest events in oncogenesis.
openaire   +2 more sources

Response criteria for phase II studies of supratentorial malignant glioma.

Journal of Clinical Oncology, 1990
We suggest "new" response criteria for phase II studies of supratentorial malignant glioma and favor rigorous criteria similar to those in medical oncology, with important modifications.
D. R. MacDonald, T. Cascino, S. Schold, J. Cairncross, G. Cairncross   +4 more
semanticscholar   +1 more source

Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma.

ACS Nano, 2018
Over the last decades, considerable efforts have been put into developing active nanocarrier systems that cross the blood brain barrier (BBB) to treat brain-related diseases such as glioma tumors.
Kelong Fan, Xiao-hua Jia, Meng Zhou, Kun Wang, J. Conde, Jiuyang He, Jie Tian, Xiyun Yan   +7 more
semanticscholar   +1 more source